5 Beaten-Down Biotech Bets to Bounce Back in 2022

Published on December 31, 2021

Biotech stocks from the Medical sector, including APTO, CELU, CNSP, CYAD and SPRB, might be witnessing a turnaround in 2022 to emerge as solid investment options.